
==== Front
Nat Med
Nat Med
Nature Medicine
1078-8956
1546-170X
Nature Publishing Group US New York

39075282
3207
10.1038/s41591-024-03207-z
Author Correction
Author Correction: Anakinra in Sanfilippo syndrome: a phase 1/2 trial
http://orcid.org/0000-0002-2881-6138
Polgreen Lynda E. lpolgreen@lundquist.org

12
http://orcid.org/0000-0003-4084-2838
Chen Agnes H. 12
Pak Youngju 12
Luzzi Anna 1
Morales Garval Adolfo 1
http://orcid.org/0000-0002-3012-5547
Acevedo Jonathan 1
http://orcid.org/0000-0001-7046-3754
Bitan Gal 3
Iacovino Michelina 12
O’Neill Cara 4
http://orcid.org/0000-0001-5340-017X
Eisengart Julie B. 5
1 https://ror.org/025j2nd68 grid.279946.7 0000 0004 0521 0744 Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA USA
2 grid.19006.3e 0000 0000 9632 6718 Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA USA
3 https://ror.org/046rm7j60 grid.19006.3e 0000 0001 2167 8097 Department of Neurology, David Geffen School of Medicine, Brain Research Institute and Molecular Biology Institute University of California, Los Angeles, Los Angeles, CA USA
4 Cure Sanfilippo Foundation, Columbia, SC USA
5 grid.17635.36 0000000419368657 Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN USA
29 7 2024
29 7 2024
2024
30 9 26932693
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Subject terms

Phase II trials
Paediatric neurological disorders
issue-copyright-statement© Springer Nature America, Inc. 2024
==== Body
pmcCorrection to: Nature Medicine 10.1038/s41591-024-03079-3, published online 21 June 2024.

In the version of the article initially published, two references were missing and have now been added as refs. 13 and 14: Parker, H. et al. Haematopoietic stem cell gene therapy with IL-1Ra rescues cognitive loss in mucopolysaccharidosis IIIA. EMBO Mol. Med. 12, e11185 (2020) and Mandolfo, O., Parker, H. & Bigger, B. Innate immunity in mucopolysaccharide diseases. Int. J. Mol. Sci. 23, 10.3390/ijms23041999 (2022). Citations of these references have been added to the fourth paragraph of the introduction, and the first paragraph of the Discussion. These corrections have been made to the HTML and PDF versions of the article.
